Fundraising Fox
BioIntelliSense
Golden, US · Founded 2019 · Delaware corporation · 83 employees on LinkedIn · 4 known investors
Find your way into BioIntelliSense
Sign up to see every warm intro you have to BioIntelliSense
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioIntelliSense team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care. Founded in 2019, the company builds medical monitoring solutions for healthcare providers and patients.
Founders & leadership
BioIntelliSense was founded in 2019 by James Mault.
JM
James MaultExecutive Chairman and FounderA surgeon by training, he started BioIntelliSense in 2018 and led it as CEO until 2025, when he moved into the executive chairman role. He is a founding board member of the Remote Monitoring Leadership Council, has served on boards and standards committees at the Consumer Technology Association since 2013, sits on M42 Health's medical advisory board and the Astronaut Scholarship Foundation's board of trustees, and was a director of the American Telemedicine Association from 2021 to 2025.
DW
David WangCEODavid Wang is Executive Officer and Director at BioIntelliSense, which develops physiologic monitoring technology for continuous patient monitoring in healthcare settings.
RC
Ronald ChwangNamed on SEC filing
AM
Alan MeekerNamed on SEC filing
LL
Larry LeisureNamed on SEC filing
SH
Steve HessNamed on SEC filing
Board
CM
Conlan MaBoard director
XY
Xinyaun YuBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$140.3M disclosed across 4 rounds · 2018–2025
▶$58.3MraisedJun 2026 · 14 investors · OtherRule 506(b)
▶$58.3MraisedJun 2026 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Conlan MaDirector
- David WangExecutive Officer, Director
- Xinyaun YuDirector
- James MaultExecutive Officer, Director
- Offering amount
- $58.4M
- Amount sold
- $58.3M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45MraisedSep 2022 · 16 investors · Other Health CareRule 506(b)
▶$45MraisedSep 2022 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David WangExecutive Officer
- Alan MeekerDirector
- James R. MaultExecutive Officer, Director
- John DriscollDirector
- Lawrence LeisureDirector
- Steve HessDirector
- Offering amount
- $45M
- Amount sold
- $45M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$25MraisedSep 2020 · 22 investors · Other Health CareRule 506(b)
▶$25MraisedSep 2020 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steve HessDirector
- Alan MeekerDirector
- Larry LeisureDirector
- Ronald ChwangDirector
- James MaultExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$12MraisedSep 2020 · 11 investors · Other Health CareRule 506(b)
▶$12MraisedSep 2020 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James MaultExecutive Officer, Director
- Ronald ChwangDirector
- Alan MeekerDirector
- Larry LeisureDirector
- Steve HessDirector
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
LifeSignalsLifeSignals develops silicon-based biosensor platforms and wearable monitoring solutions that enable clinical-grade health measurement outside traditional healthcare settings. The company targets widespread access to hospital-quality biomedical monitoring for individuals regardless of geographic proximity to medical facilities or economic status.
BiotricityBiotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
BiofourmisBiofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care. It serves healthcare providers and partners, aiming to reduce hospital readmissions and cost of care.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
BiolinqBiolinq develops glucose-sensing technology based on micro-array biosensors for metabolic health monitoring, including continuous glucose monitoring. The company works in the medical device and diagnostics space, with a team drawn from continuous glucose monitoring and diabetes device backgrounds.
Companies working in the same space as BioIntelliSense.
In the news
Frequently asked questions
- What does BioIntelliSense do?
- BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care. Founded in 2019, the company builds medical monitoring solutions for healthcare providers and patients.
- Who founded BioIntelliSense?
- BioIntelliSense was founded by James Mault in 2019.
- Who are BioIntelliSense's investors?
- BioIntelliSense's investors include Bose Ventures, CU Healthcare Innovation Fund, Fresenius Medical Care Ventures, SkyPoint Ventures.
- How much funding has BioIntelliSense raised?
- BioIntelliSense has disclosed $140.3M raised across 4 rounds.
- Where is BioIntelliSense headquartered?
- BioIntelliSense is headquartered in Golden, US.